Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Strategic Use of New Generation Antidepressants for Depression.

Next Previous
Trial Profile

Strategic Use of New Generation Antidepressants for Depression.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Jan 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mirtazapine (Primary) ; Sertraline (Primary)
  • Indications Depression; Depressive disorders
  • Focus Therapeutic Use
  • Acronyms SUN-D

Most Recent Events

  • 20 May 2013 Planned end date changed from 1 Mar 2013 to 1 Oct 2015 as reported by ClinicalTrials.gov.
  • 28 Feb 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
  • 26 Apr 2010 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top